Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
I have been monitoring the house building sector for a while and there are only a few remaining big players to be swallowed up. Crest has under performed for the last few years maybe this is a good deal
I'm waiting to see who buys CALA homes but looks like its not Bellway
Spring field properties - 94p Scottish play
Watkin jones 45p
GLE affordable homes £5.30
PEN buys CALA?
But all politicians are saying build more houses so any house builder is a great bet for a labour or ny other victory
How much could it cost? In May 2024, Johnson & Johnson (J&J) announced a $6.48 Billion talc settlement proposal for the thousands of lawsuits that claim the company's baby powder and talc products cause ovarian cancer. Nearly 60,000 talc-related lawsuits have been filed against Johnson & Johnson, with around 99% involving ovarian cancer.
UK construction grows at fastest pace in over a year
S&P Global's UK construction PMI, which measures the industry's output every month, came in at 53 in April, improving from 50.2 the month prior and remaining above the 50 mark which separates indicates whether the sector is in decline or is expanding.
While the research found the sector was at its highest output in 14 months, the survey also indicated the housebuilding slowed at its worst rate since January.
Tim Moore, economics director at S&P Global, said: "Commercial construction outperformed in April and civil engineering also provided a solid contribution to overall growth.
"Lacklustre market conditions in the house building segment continued to weigh on activity."
Increased offer to 39p all cash really poor to sell out at this price, considering the diverse portfolio that accl were developing
Company has been building a portfolio of factories and brands then sells out at a ridiculously low level?
Drifting down before the interim results
Up 250% since Jan 2023 yet not much chat about this share
three heavy holders hold 50 % teleios Capital Partners GmbH DUMAC, Inc.Zama Capital Advisors LP
Tim has 40 years’ international senior level business experience in high growth biotech, healthcare and technology companies. He is also Chairman of Incanthera plc and 4basebio plc. Tim was formerly CEO and CFO of a number of UK public listed and private companies including, including Alizyme plc and Peptide Therapeutics Group plc, and has a core understanding of AIM and its regulatory processes. Co-founding a number of healthcare and biotechnology companies, he has helped raise substantial amounts of equity capital and also advised and worked at Board level for a diverse range of companies internationally, in areas such as business strategy, mergers & acquisitions, due diligence and licensing. And then they went bust
When are we going to see an update as they off-load chrome division will the shares be going up or will an other offer come in before
Still great growth potential with 2021 buys of wet wipes, john dale purchase north wales, and tissue plant I'm buying at 11p